Q1 2021 Holdings
Filed 2021-05-17 | 86 holdings | $952.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $234.0M | 849,845 | 24.6% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $202.7M | 2,532,523 | 21.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $96.3M | 3,458,830 | 10.1% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $72.2M | 978,600 | 7.6% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $71.5M | 1,158,082 | 7.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $69.8M | 3,387,788 | 7.3% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $48.3M | 166,679 | 5.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $45.6M | 162,847 | 4.8% |
| Avita Medical Inc(RCEL) | COM | 05380C102 | $33.1M | 1,668,327 | 3.5% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $23.3M | 3,514,100 | 2.4% |
| Bioventus Inc(BVS) | COM CL A | 09075A108 | $22.9M | 1,500,000 | 2.4% |
| Cytosorbents Corp(CTSO) | COM NEW | 23283X206 | $18.5M | 2,127,631 | 1.9% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $7.7M | 696,378 | 0.8% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.1M | 12,957,222 | 0.1% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $277.7K | 2,419,418 | 0.0% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $262.7K | 3,425,455 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $208.6K | 21,114,114 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $195.1K | 4,351,644 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $185.4K | 4,852,163 | 0.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $178.4K | 7,308,418 | 0.0% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $164.3K | 5,619,914 | 0.0% |
| Medavail Holdings Inc | COM | 58406B103 | $164.1K | 11,724,726 | 0.0% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $159.0K | 2,930,411 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $158.7K | 2,060,132 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $136.3K | 829,159 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $130.1K | 937,045 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $126.1K | 3,207,193 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $125.6K | 4,118,212 | 0.0% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $115.7K | 979,108 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $110.3K | 2,176,628 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $103.0K | 3,314,117 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $101.2K | 2,603,139 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $98.9K | 6,885,233 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $98.8K | 2,544,062 | 0.0% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $96.4K | 2,221,044 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $85.8K | 3,589,342 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $82.6K | 1,119,830 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $81.8K | 2,665,496 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $80.0K | 2,751,815 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $79.9K | 222,458 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $79.8K | 2,340,313 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $79.7K | 3,610,788 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $78.5K | 9,688,066 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $76.9K | 8,824,366 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $72.9K | 2,513,746 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $72.1K | 516,795 | 0.0% |
| Cigna Corp New(CI) | COM | 125523100 | $67.7K | 280,057 | 0.0% |
| Selectquote Inc(SLQT) | COM | 816307300 | $59.2K | 2,005,054 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $50.7K | 4,117,569 | 0.0% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $47.5K | 4,541,009 | 0.0% |